Evidence map›Paper›PMID 24535840›Full record

ArticleBirth defects research. Part A, Clinical and molecular teratology2014

Is low iron status a risk factor for neural tube defects?

Anne M Molloy, Caitriona Nic Einri, Divyanshu Jain, Eamon Laird, Ruzong Fan, Yifan Wang, John M Scott, Barry Shane, Lawrence C Brody, Peadar N Kirke and 1 more

Abstract read
In one paragraph

Article in Birth defects research. Part A, Clinical and molecular teratology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Anne M MolloyThe Institute of Molecular Medicine, School of Medicine, Trinity College Dublin, Ireland.
Caitriona Nic Einri
Divyanshu Jain
Eamon Laird
Ruzong Fan
Yifan Wang
John M Scott
Barry Shane
Lawrence C Brody
Peadar N Kirke
James L Mills
Trinity College Dublin · IENational Institutes of Health · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USHealth Research Board · IENational Human Genome Research Institute · USUniversity of California, Berkeley · US

Funding

The contribution folate and vitamin B12 genes to disease.ZIAHG000167 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BRODY, LAWRENCE C · 2009 to 2025
$17.6M
NICHD Health Research Board Of Ireland Neural Tube Defects StudyZIAHD002502 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MILLS, JAMES · 2009 to 2022
$2.9M
FOLATE AND NEURAL TUBE DEFECTS-275033348N01HD033348 · NICHD · THE HEALTH RESEARCH BOARD · 2003 to 2004
–
NICHD NIH HHS N01 HD033348
6 · The paper itself

Abstract

backgroundFolic acid supplements can protect against neural tube defects (NTDs). Low folate and low vitamin B12 status may be maternal risk factors for having an NTD affected pregnancy. However, not all NTDs are preventable by having an adequate folate/ B12 status and other potentially modifiable factors may be involved. Folate and vitamin B12 status have important links to iron metabolism. Animal studies support an association between poor iron status and NTDs, but human data are scarce. We examined the relevance of low iron status in a nested NTD case-control study of women within a pregnant population-based cohort.

methodsPregnant women were recruited between 1986 and 1990, when vitamin or iron supplementation in early pregnancy was rare. Blood samples, taken at an average of 14 weeks gestation, were used to measure ferritin and hemoglobin in 64 women during an NTD affected pregnancy and 207 women with unaffected pregnancies.

resultsNo significant differences in maternal ferritin or hemoglobin concentrations were observed between NTD affected and nonaffected pregnancies (case median ferritin 16.9 µg/L and hemoglobin 12.4 g/dl versus 15.4 µg/L and 12.3g/dl in controls). As reported previously, red cell folate and vitamin B12 concentrations were significantly lower in cases. Furthermore, there was no significant association of iron status with type of NTD lesion (anencephaly or spina bifida).

conclusionWe conclude that low maternal iron status during early pregnancy is not an independent risk factor for NTDs. Adding iron to folic acid for periconceptional use may improve iron status but is not likely to prevent NTDs.

Indexed as

AdultAnencephalyCase-Control StudiesFemaleFerritinsHemoglobinsHumansInfant, NewbornIronRisk FactorsSpinal DysraphismFerritinsHemoglobinsIronferritinhemoglobinironneural tube defects

Identifiers

PMID24535840
PMCPMC4018583
OpenAlexW2169083793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.